health care professionals

We have repeatedly discussed the adverse effects of conflicts of interest on health care.  Recently, I argued that the most pernicious are conflicts of interest created as an incentive for trusted health care leaders, usually respected health care professionals or academics, to promote the vested interests of those who pay them, in the guise of the leaders' professional roles.  In this capacity, the leaders are often dubbed "key opinion leaders" by those who employ them, but may be rega

Since Enthoven called for the break up of the physicians' "guild," and handing over its supposed power to managers, (see post here) managers have taken over from physicians and other health care professionals as leaders of health care organizations.  Unfortunately, most of these managers are generic, often lacking knowledge and experience in health care, and understanding of its core values.  Instead, such generic man

Innovative winners of an HHS public data and cancer challenge have created health IT applications that use public data and existing technology to help patients and health care professionals prevent, detect, diagnose and treat cancer.

(John Theurer Cancer Center) The Lymphoma Division of the John Theurer Cancer Center at Hackensack University Medical Center with the participation from the Facebook groups “Hope for Lymphoma” and “Our MCL Family,” will host its first-ever Mantle Cell Lymphoma Symposium on Saturday, November 12 from 8:30 a.m.-3:45 p.m.

The event is open to both health-care professionals and also to Mantle Cell Lymphoma (MCL) patients and their caregivers coping with this challenging diagnosis

(Society of Interventional Radiology) The Society of Interventional Radiology has a long-term commitment to radiation safety and takes the lead in promoting the safety of patients and health care professionals.

Four articles, published this month in the Journal of Vascular and Interventional Radiology, illustrate SIR's frontline stance on facets of patient safety and standards of care to protect both patients and the diagnostic and interventional radiologist.

In our side-bar to the right we have a section for "Upcoming Meetings and Events."  Sadly, it is often empty.  Perhaps as a result of the anechoic effect, there seem to be few talks, workshops, much less symposia, conferences, and courses on the issues we discuss on Health Care Renewal. 

However, I am happy to now note two upcoming events of interest.

A new blog, entitled the Medical Professionalism Blog, signed on last week with a post emphasizing some themes that should be familiar to Health Care Renewal readers:

There is an increasing focus on the sustainability of the U.S. health care system based on current cost trends.

Predictions are for the health care system to consume 19% of the GDP by 2019. How did we get here?

In discussing how concentration and abuse of power threatens health care professionals' values and professionalism, we have discussed how ostensibly academic institutions value faculty more for their earning power than their academic abilities.  We have discussed how financial relationships between physicians and drug, biotechnology, device and other companies risk abuse of entrusted power.  But up to now,

The FDA has issued a safety announcement notifying health care professionals that it has updated the pregnancy section of drug labels for the entire class of antipsychotic medications.

For five years now, we have been writing about concentration and abuse of power in health care, and on specific tactics used predominantly by large health care organizations that threaten the values that physicians and other health care professionals once swore to uphold.